
Annex 11 vs Part 11
Explore this topic in more depth to build a complete picture of your quality and compliance operations.
ExploreThe EU's computerised-systems rules for GMP — and the biggest revision in over a decade is imminent.
Annex 11 is the EU counterpart every Part 11 conversation eventually reaches: system-and-lifecycle-centric rules for computerised systems in GMP, currently being rewritten for the cloud and AI era.

Annex 11 — Computerised Systems is part of EudraLex Volume 4, the EU's Good Manufacturing Practice guidelines for medicinal products for human and veterinary use. It applies to any computerised system used as part of GMP-regulated activities, and it is system-and-lifecycle-centric: where the US Part 11 focuses on electronic records and signatures, Annex 11 governs the whole life of the system that produces them.
The text in force is the 2011 revision — a deliberately principle-based document covering risk management, supplier and service-provider responsibility, validation, data, accuracy checks, data storage, printouts, audit trails, change and configuration management, periodic evaluation, security, incident management, electronic signatures, batch release, business continuity, and archiving. PIC/S publishes an equivalent Annex 11 used by participating authorities beyond the EU.
A draft revised Annex 11 was published on 7 July 2025 — alongside a brand-new Annex 22 on Artificial Intelligence and a revised Chapter 4 on documentation — with public consultation closed in October 2025 and the final version expected around mid-2026. The draft grows the 2011 text substantially: explicit expectations for cloud and SaaS, cybersecurity controls, and sharper accountability for regulated users of outsourced services. Until adoption, the 2011 text remains the version in force.
For any company manufacturing or releasing product for the EU market, Annex 11 is the lens an EU inspector applies to every computerised system in GMP scope — the eQMS included. The questions follow its clauses: is the system validated for its intended use, who is responsible for it, what does the supplier do versus what do you do, is the data accurate and protected, can you show an audit trail, what happens when the system changes, and what happens when it fails.
Two Annex 11 themes hit cloud eQMS buyers hardest. First, supplier responsibility: outsourcing the system never outsources the accountability — the regulated user must understand and oversee what the provider does. Second, lifecycle governance: validation is not a go-live event but a state to be maintained through change control and periodic evaluation. The 2025 draft revision sharpens both, adding explicit cybersecurity and service-oversight expectations.
Annex 11 never operates alone. The pieces it interlocks with:
In practice, Annex 11 review is concrete: a validated state with evidence proportionate to risk; an inventory of GMP computerised systems; documented supplier assessment for outsourced services; controlled access with individual accounts; an audit trail that records GMP-relevant changes and deletions and is reviewed; change management with evaluated impact; periodic evaluation that confirms the validated state still holds; data backup, archiving, and a tested business continuity arrangement.
For cloud systems, the assessment extends into the provider: hosting model, data location, isolation, the provider's own change and release discipline, and how the customer learns about changes that affect the validated state.
Complere's controls were built with Annex 11's clause structure in mind: role-based access with individual accounts, time-stamped audit trails on regulated records, electronic signatures with re-authentication, controlled change with impact assessment, and per-tenant isolation with customer-selected hosting region. The validation pack delivers the lifecycle evidence Annex 11 expects — and is regenerated on releases that affect validated functionality, supporting the periodic-evaluation posture. The clause-level walkthrough is on Electronic Records & Signatures and the Annex 11 validation playbook.
Common questions about EU GMP Annex 11 sourced from regulatory references and inspection patterns.
Part 11 (US FDA) is record-and-signature-centric: it governs electronic records and signatures used in place of paper. Annex 11 (EU GMP) is system-and-lifecycle-centric: it governs the whole computerised system — validation, suppliers, security, change, periodic review, business continuity. Global systems generally need to satisfy both.
Annex 11 is part of EudraLex Volume 4, the EU GMP guidelines that interpret the GMP directives. In practice it carries the force of GMP expectation: EU inspectors assess computerised systems against its clauses, and gaps surface as GMP deficiencies.
A draft revised Annex 11 was published on 7 July 2025 — together with a new draft Annex 22 on artificial intelligence and a revised Chapter 4 — with public consultation closed in October 2025 and final adoption expected around mid-2026. Until adoption, the 2011 text remains in force. The draft adds explicit cloud/SaaS, cybersecurity, and service-provider-oversight expectations.
Yes. The 2011 text already covers outsourced services through its supplier clauses — the regulated user stays accountable for systems run by providers. The draft revision makes cloud expectations explicit: provider oversight, data location, security controls, and knowing how provider changes affect your validated state.
Walk through the modules and workflows that address this area inside a controlled, validation-ready quality system.
Explore related topics, modules, and compliance resources for a deeper understanding of your quality system.

Explore this topic in more depth to build a complete picture of your quality and compliance operations.
Explore
Explore this topic in more depth to build a complete picture of your quality and compliance operations.
Explore
Explore this topic in more depth to build a complete picture of your quality and compliance operations.
Explore